Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

NCT01546571 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

504

Enrollment

INDUSTRY

Sponsor class

Stopped After interim analysis the study was halted to redesign a pivotal trial.

Conditions

Melanoma

Interventions

BIOLOGICAL: POL-103A
BIOLOGICAL: POL-103A without API

Sponsor

Polynoma LLC